Ask the Vet LIVE: Equine Osteoarthritis Now Archived
The Horse Staff
October 19, 2012
Our experts answer your questions about preventing, treating, and managing equine OA.
Our experts answer your questions about preventing, treating, and managing equine OA.
Osteoarthritis (OA) is a degenerative and career-compromising disease in horses.
Could an 18-year-old active Quarter Horse with bone spavin be a candidate for alcohol joint fusion?
Study shows this treatment for mild osteoarthritis has longer lasting effects than previously thought.
One veterinarian shares his thoughts on the past, present, and future of stem cells in equine medicine.
Study finds that dexamethasone (DXM) behaves similarly regardless of how it enters the horse’s body.
Firocoxib improved lameness scores, comfort, and mobility in most horses with osteoarthritis, a study showed.
Joint disease is a common lameness cause and a primary reason why many horses’ athletic careers end.
Patella infections in foals, while uncommon, can result in prolonged and severe stifle joint infection.
The study will test a novel neutriceutical for the treatment of lameness in horses due to osteoarthritis.
A green-lipped mussel-derived product could be useful for combating some signs of osteoarthritis in horses.
Cornell University researchers are examining the use of degradable pins for treating OCD lesions in horses.
We’ll explore how the horse’s body systems age and what to look out for in your equine senior citizen.
Supplements, polysulfated glycosaminoglycans, and regenerative medicines are some approaches for treating OA.
Researchers recently investigated how certain arthritic joint tissues respond to treatments such as shock wave.
Fluid caused little reaction in some horses’ stem cells but promoted or inhibited growth in others.
Stay on top of the most recent Horse Health news with
